Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34946105061;105062;105063 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
N2AB33305100138;100139;100140 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
N2A3237897357;97358;97359 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
N2B2588177866;77867;77868 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
Novex-12600678241;78242;78243 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
Novex-22607378442;78443;78444 chr2:178531779;178531778;178531777chr2:179396506;179396505;179396504
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-163
  • Domain position: 5
  • Structural Position: 5
  • Q(SASA): 0.4136
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/R rs1185207035 None 0.999 N 0.707 0.535 0.774190524746 gnomAD-4.0.0 2.05242E-06 None None None None I None 0 0 None 0 0 None 0 0 8.99402E-07 0 3.31268E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8831 likely_pathogenic 0.9239 pathogenic -0.996 Destabilizing 0.983 D 0.439 neutral None None None None I
L/C 0.951 likely_pathogenic 0.9658 pathogenic -0.753 Destabilizing 1.0 D 0.659 neutral None None None None I
L/D 0.9954 likely_pathogenic 0.9979 pathogenic -0.313 Destabilizing 0.999 D 0.73 prob.delet. None None None None I
L/E 0.9588 likely_pathogenic 0.981 pathogenic -0.363 Destabilizing 0.999 D 0.743 deleterious None None None None I
L/F 0.7462 likely_pathogenic 0.8424 pathogenic -0.706 Destabilizing 0.998 D 0.611 neutral None None None None I
L/G 0.9716 likely_pathogenic 0.9815 pathogenic -1.234 Destabilizing 0.999 D 0.728 prob.delet. None None None None I
L/H 0.9411 likely_pathogenic 0.9713 pathogenic -0.369 Destabilizing 1.0 D 0.697 prob.neutral None None None None I
L/I 0.3326 likely_benign 0.4107 ambiguous -0.462 Destabilizing 0.923 D 0.397 neutral None None None None I
L/K 0.9193 likely_pathogenic 0.9576 pathogenic -0.629 Destabilizing 0.999 D 0.705 prob.neutral None None None None I
L/M 0.3662 ambiguous 0.4342 ambiguous -0.437 Destabilizing 0.997 D 0.618 neutral N 0.431009825 None None I
L/N 0.9653 likely_pathogenic 0.9807 pathogenic -0.465 Destabilizing 0.999 D 0.724 prob.delet. None None None None I
L/P 0.9897 likely_pathogenic 0.9945 pathogenic -0.606 Destabilizing 0.999 D 0.73 prob.delet. N 0.463159529 None None I
L/Q 0.8226 likely_pathogenic 0.9055 pathogenic -0.663 Destabilizing 0.999 D 0.703 prob.neutral N 0.388330909 None None I
L/R 0.8568 likely_pathogenic 0.9305 pathogenic -0.029 Destabilizing 0.999 D 0.707 prob.neutral N 0.424427782 None None I
L/S 0.9457 likely_pathogenic 0.9712 pathogenic -1.021 Destabilizing 0.998 D 0.666 neutral None None None None I
L/T 0.8645 likely_pathogenic 0.9146 pathogenic -0.957 Destabilizing 0.983 D 0.549 neutral None None None None I
L/V 0.2834 likely_benign 0.3895 ambiguous -0.606 Destabilizing 0.198 N 0.181 neutral N 0.376809981 None None I
L/W 0.9236 likely_pathogenic 0.9648 pathogenic -0.72 Destabilizing 1.0 D 0.685 prob.neutral None None None None I
L/Y 0.9476 likely_pathogenic 0.9688 pathogenic -0.496 Destabilizing 0.999 D 0.679 prob.neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.